Literature DB >> 143965

Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase.

Y Tamura, M Hirado, K Okamura, Y Minato, S Fujii.   

Abstract

p-Carbethoxyphenyl episol-guanidinocaproate and p-(p'-guanidinobenzoyloxy)-phenyl derivatives were prepared, and their inhibitory effects on trypsin, plasmin, plasma kallikrein, thrombin, C1r- and C1 esterase were examined. Among the various inhibitors tested, p-nitrophenyl p'-guanidinobenzoate, N,N-dimethylamino p-(p'-guanidinobenzoyloxy)-benzoyl glycolate and N,N-dimethylamino p-(p'-guanidinobenzoyloxy)-benzilcarbonyloxy glycolate were the most effective inhibitors of trypsin, plasmin, plasma kallikrien and thrombin, and they strongly inhibited the esterolytic activities of C1r- and C1 esterase.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 143965     DOI: 10.1016/0005-2744(77)90097-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  38 in total

1.  The cholecystokinin receptor antagonist L-364,718 reduces taurocholate-induced pancreatitis in rats.

Authors:  K H Kim; M G Lee; D G Kim
Journal:  Int J Pancreatol       Date:  1996-12

2.  Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.

Authors:  T Akahoshi; H Sugimori; N Kaku; K Tokuda; T Nagata; E Noda; M Morita; M Hashizume; Y Maehara
Journal:  Eur J Trauma Emerg Surg       Date:  2014-11-20       Impact factor: 3.693

3.  Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.

Authors:  Kamal Albarazanji; Matthew Jennis; Cassandre R Cavanaugh; Wensheng Lang; Bhanu Singh; James C Lanter; James M Lenhard; Pamela J Hornby
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-28       Impact factor: 4.052

4.  Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.

Authors:  C Niederau; R A Liddle; L D Ferrell; J H Grendell
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

5.  A Novel, Nonpeptidic, Orally Active Bivalent Inhibitor of Human β-Tryptase.

Authors:  Sarah F Giardina; Douglas S Werner; Maneesh Pingle; Donald E Bergstrom; Lee D Arnold; Francis Barany
Journal:  Pharmacology       Date:  2018-08-22       Impact factor: 2.547

6.  In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinine.

Authors:  J Freise; H Wittenberg; P Magerstedt
Journal:  Klin Wochenschr       Date:  1989-02-01

7.  Rabeprazole is effective for bile reflux oesophagitis after total gastrectomy in a rat model.

Authors:  Naoki Hashimoto
Journal:  World J Gastrointest Pathophysiol       Date:  2015-02-15

8.  Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.

Authors:  M Otsuki; S Tani; Y Okabayashi; M Fuji; T Nakamura; T Fujisawa; H Itoh
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

9.  Influence of plasma proteinase inhibitors and the secretory leucocyte proteinase inhibitor on pancreatic elastase-induced degradation of some plasma proteins.

Authors:  H O Håkansson; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1992-10

10.  The therapeutic effect of a new synthetic protease inhibitor (E-3123) on hemodynamic changes during experimental acute pancreatitis in dogs.

Authors:  K Satake; S S Ha; A Hiura; H Nishiwaki
Journal:  Gastroenterol Jpn       Date:  1993-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.